Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial.

Ramavath Devendra Naik,Sreenivas Vishnubhatla,Vishwajeet Singh,Ashwati S. Pillai,Deepa Dhawan,Sameer Bakhshi

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial.

2020

Ramavath Devendra Naik
Sreenivas Vishnubhatla
Vishwajeet Singh
Ashwati S. Pillai
Deepa Dhawan
Sameer Bakhshi

PURPOSEChemotherapy-induced nausea and vomiting (CINV) is a significant toxicity of chemotherapy. Olanzapine is recommended in adult patients for the prevention of CINV but has not been prospective...

Keywords:

Vomiting
Olanzapine
open label
Chemotherapy
Internal medicine
Medicine
adult patients
Nausea
highly emetogenic chemotherapy
Toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations